HCC

For intermediate-stage HCC, transarterial chemoembolization is the mainstay of treatment but is only possible in a minority of patients.

Hepatocellular carcinoma(HCC) is one of the most common malignant tumors, whose mechanism remains elusive.

Heterogeneity in reporting means that these data may underestimate the rate of disease progression, particularly HCC development.

Hepatology Digest: From your experience, RFA is an efficient treatment for HCC. What are the indications and contraindications for RFA?

For those patients with advanced HCC, who have had surgical resection, with the surgery impact the safety and efficacy of sorafenib ?

Incidence rates of hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) have increased in the United States.

The aim of this review is to provide an up-to-date summary of recent advances in the field of HCC.

However, with advances in different treatment modalities for HCC, the incidence of extrahepatic metastasis appears to be increasing.

International Digest: Most HCC is not diagnosed until the disease is at an advanced stage.

Although these patients receive systemic treatment including chemotherapy, HCC is generally recognized as a chemo-resistant tumor.

Incorporation of these molecular markers could help to improve organ allocation for HCV-HCC patients.

Due to the proclivity of HCC for early micrometastases, immunosuppressive therapy can induce significant metastatic lesions.

The current data suggest that there is no role for pre-transplant therapy for HCC within Milano criteria transplanted within six months.

Background & Aims Hepatocellular Carcinoma (HCC) is one of the most common malignant tumor in the world.

Objective To investigate the possibility of using telomerase as a tumor marker for human primary hepatocellular carcinomas (HCC).

Hepatology Digest: At present, interventional therapy is still the more effective treatment strategy for unresectable HCC patients.

HCC is a very diverse community. In this community, each one of us is a witness of Christ.

HCC( hepatocellular carcinoma) poses a significant disease burden in many parts of the world.

BACKGROUND: Liver transplantation (LT) represents a curative treatment for small hepatocellular carcinoma (HCC).

At present, interventional therapy is still the more effective treatment strategy for unresectable HCC patients.

Those guidelines also established noninvasive diagnostic criteria for HCC that the expert panel accepted for trial design.

The median survival of HCC is less than 12 months from diagnosis, reflecting both late diagnosis and lack of effective therapy.

ABSTRACT: Objective To evaluate the prognostic value of surgical operation-related factors in patients with hepatocellular carcinoma (HCC).

Hepatology Digest: Do you think HCC is a major indication for living donor transplantation? Why or why not?

The primary aim of the present study was to evaluate the impact of waitlist time on HCC recurrence.

These signatures predict early and overall recurrence in patients with HCC, and complement findings from clinical and pathology analyses.

Objective: To explore the diagnosis, surgical treatment and outcome of hepatocellular carcinoma(HCC) with tumor thrombus in bile duct (BDT).

Treatment options for HCC include chemotherapy, chemoembolization, ablation and proton-beam therapy.

OBJECTIVE: To explore the role of arsenious acid on tumor recurrence in liver transplant patients with primary HCC extending Milan criteria.

Methods The published papers on current situation and advance in the perioperative therapy of liver transplantation for HCC were reviewed.

The combination of sorafenib and doxorubicin in patients with advanced HCC has not been evaluated in a phase 2 or 3 trial.

Hepatocellular carcinoma(HCC) is one of malignant tumor having the highest death rate worldwide.

The repeated injury and regeneration of liver cells, fibrosis and cirrhosis are three major stages of hepatocarcinogenesis.

An older age at time of cirrhosis diagnosis and a higher BMI were negatively associated with the development of HCC.

Hepatocellular carcinoma (HCC) is an aggressive tumor with poor long-term prognosis.

The team is currently testing small molecule inhibitors of LSF as a possible therapy for HCC in animal models.

However, overall and HCC-specific survival were similar between the two groups.

The projected frequency of liver failure and HCC due to NASH is expected to equal or surpass that due to hepatitis C.

The Cleveland Clinic study established that NASH-induced cirrhosis is a much greater risk factor for HCC than previously thought.

To investigate the correlation between the polymorphism of PTEN gene and the prognosis of HCC(Hepatocelluar Carcinoma) patients.

Early HCC frequently shows rowing tense on hepatocyte phase image and dysplastic nodule not show rowing tense on MR for hepatocyte images.

Conclusion: Both Tetrandrine and Cisplatin could inhibit the growth of the transplanted HCC in mice.

In an effort to address these issues, treatment of HCC in patients awaiting LT has become widespread practice.

HCC rarely develops in patients with cirrhosis due to Wilson's disease or primary biliary cirrhosis.

At HCC, we sometimes interchange the usage of these two terms.

Tumor microvessels typing degree is higher in low-grade differentiation level HCC, large HCC and HCC without envelope.

"Taken together, our study suggests that EPCs may have a significant implication in HCC in terms of prognosis, " the authors note.

Metastatic hepatocellular carcinoma (HCC)to the right atrium occurs rarely and may lead to lethal perioperative complications.

Objective To investigate the risk factors associated with HCC arising in CC(cryptogenic cirrhosis).

There is no established molecular cla ification of HCC, although preliminary proposals have already been published.

HCC is generally hypervascular, and vascular endothelial growth factor (VEGF) promotes HCC development and metastasis.

Infection with hepatitis C virus (HCV) can cause chronic hepatitis, cirrhosis, and even hepatocellular carcinoma (HCC).

Objective To evaluate the value of transcatheter arterial embolization (TAE) in spontaneous rupture of hepatocellular carcinoma (HCC).

But considering the trend of cryptography in recent years, ECC and HCC will be the biggest winner in the cryptography field.

Systemic chemotherapies are minimally effective in advanced HCC and less so as neo-adjuvant therapy.

Further clinical trials using biologic agents are warranted to prolong the survival in HCC patients.

Yes, just as we know, now the curative effect of HCC has improved more compare to the past.

ACHE is a promising independent prognostic predictor for HCC recurrence and the survival of HCC patients.

Objective: To investigate the expression and clinical significance of IL-17 in primary human hepatocellular carcinoma (HCC).

In this study, we aimed to assess the relationship between pre-chemotherapy HBV viral load and the survival of HCC patients.

Objective To evaluate surgical therapy and the effect for primary hepatocellular carcinoma(HCC)with tumor thrombi in the bile duct.

Objective To evaluate the clinical value of multislice spiral CT angiography (MSCTA) on hepatocellular carcinoma (HCC).

Conclusion Primary resistance existed in HCC and there were many mechanisms of multidrug resistance.

have first-degree relatives with HCC should be offered treatment.

Objective To investigate the effect of postoperative prophylactic TACE on delaying recurrence in HCC patients with microvascular invasion.

Hepatology Digest : When we compare to other types of tumors, what are the prospects for HCC in targeted therapy?

CONCLUSIONS: We developed a composite prognostic model for HCC recurrence, based on gene expression patterns in tumor and adjacent tissues.

The horizontally continuous cast (HCC) round steel is a kind of multi - g crystal, elastic - anisotropic and coarse-grained material.

Conclusion: TCM could lessen postoperative fever in HCC patients after TACE.

The individualized protocol based on ATP TCA may be effective for patients with HCC after liver transplantation.

It is becoming more clearer that both diabetes and obesity are risk factors for hepatocellular carcinoma.

To be gratified, the curative effect of HCC has improved more compare to the past.

Would you please give us a brief introduction about the latest progress in interventional therapy for HCC?

Conclusion CEUS is real-time, effective approach in revealing the intratumoral vascularity and the perfusion of HCC.

In parts of China and the Far East, over 80% of HCC patients have chronic HBV infection.

Objective: To introduce the progress and mechanism in HCC prevention and treatment with COX-2 inhibitors.

Results indicate three factors that are statistically significant in the development of HCC within the NASH-cirrhosis group.

This report describes a 47-year woman with ruptured HCC who developed recurrent carcinomatosis .

CD44V6 expression was also related with tumor grade and PCNA expression in HCC.

What is the current study status about insulin resistance as the risk factors for HCC?

Our findings suggested that H. pylori do present in liver tissue of HCC and H. pylori has cytotoxicity on HepG2 in vitro.

Arteriovenous (AV) shunting is a special finding in HCC.

This review focuses on the role and mechanism of HBX in the pathogenesis of HCC.

Can you give us some of your suggestion and summarized for us some of the latest research related to how we can detect HCC early on?

But around 70% of early HCC shows decreased portal supply on CT arterial portography.

Kinectin antibody of the patient's serum of tumors of nervous system, HCC and some health adult were detected by ELISA.

"The study confirms the high accuracy and specificity of CEUS in the diagnosis of HCC thrombosis in cirrhotic patients, " Tarantino said.

Results The positive expression of CD44 V6 and VEGF in HCC tissues were located in membranes of cancer cells and partial cytoplasm.

We are recruiting excellent persons in the following positions with wide vocation space of HCC.

These results open a new avenue in clinical trial research in HCC.

The Role of CT in Preoperative Localization of Small HCC.

A diagnosis of hepatocellular carcinoma (HCC) was made, based on the clinical findings and CT scan.

This study observed trends toward improvement in the disease-free survival of patients with uninodular HCC 5 cm .

Beauty - is not me, but my quest -- HCC.

Antiangiogenesis is a kind of hopeful strategy for the prevention of relapse and metastasis of HCC.

The HCC increase was least dramatic among registrants with HBV.

Methods Dynamic CT scan with singe-location sequence was performed in 78 individuals including 70 patients with HCC and 8 control subjects.

Hepatocellular carcinoma (HCC) is the fifth most common carcinoma and the third leading cause of death by cancer in the world.

Could you give us a brief introduction to some of the novel therapeutic targets for HCC?

The process of angiogenesis is a cascade reaction.

HCC is a primary cancer of the liver.

TACE via the IPA is a safe and efficient for HCC.

In all, the cancer stem cell theory and the development of epigenetic may cast new lights on differentiation therapy of HCC.

In the United States, approximately 3 people per 100, 000 develop HCC each year.

Research was undertaken to gain a better understanding of the selection and use of HCC.

Only 10-20% of HCC are suitable for resection at presentation, with a 5 year recurrence-free survival of only 10-20%.

HCC shares fell as much as 6. 3 percent in early trade but later recovered in the afternoon and were flat at 1330 GMT.

Pulsatory blood flow signals within the tumor were observed in HCC 82(91. 1%)and "basket" pattern was found in 65(72. 2%).

There is strong evidence demonstrating the association of chronic HCV infection to cirrhosis and hepatocellular carcinoma (HCC).

Heptology Digest: What is your opinion about the possible mechanism for insulin-resistance causing HCC?

For early HCC, if we have a choice of radio frequency or TASS, which do you believe is the best choice?

Objective: To study the relationship between liver cirrhosis, liver cell dysplasia (LCD) and hepatocellular carcinoma (HCC).

There are more HCC cell line used to confirm the results in our study, for example, Bel-7402 HCC cell line.

Objective: To study the antitumor efficiency of Tetrandrine and Cisplatin on transplanted hepatocellular carcinoma(HCC) in mice.

Objective: To study the expressions of osteopontin (OPN) in hepatocellular carcinoma (HCC) and angiogenesis.

GSTM1 and GSTT1 combined null genotype in HCC group and control group were 38. 2% and 18. 5%, the difference was significant (P05).

Objective: To study the effects of centipede on proliferation of Hepatocarcinoma cells(HCC) and to develop a new antineoplastic therapy.

But the most important thing is that we must pay more attention to metastasis and recurrence of HCC.

Construction and expression of a humanoral recombinant immunotoxin against hepatocellular carcinoma and its killing effect on HCC cell line

Study of AFP and Imaging Monitor Diagnosis of Small Hepatocellular Carcinoma in High-risk HCC Subjects

Relationship between clinicopathologic features and tumor recurrence in HCC after liver transplantation

Clinical significance of detecting peripheral blood gene marker in the early diagnosis of metastasis of HCC

Detection of sialic acid in hepatitis involved liver cirrhosis and its significance for HCC diagnosis

Clinical significance of detection of the disseminating tumor cell before and during liver transplantation of HCC

The expression of nitric oxide synthase and its association with proliferation and apoptosis of HCC cells

Correlative Study of Spiral CT Features of HCC with Temporary Window Optimization

Hepatic Arteriovenous Transit Time Effect on Hepatic Homodynamic Changes in HCC Patients Using Contrast-enhanced Ultrasonography

Practice in prolonging service life of crystallizer for HCC

New Model of Minimally Invasive Treatment of HCC: TACE Sequentially Combined with RF Ablation and Biology-gene Treatment

Research on the non-random chromosome aberration of HCC through comparative genomic hybridization

Preliminary experience of HCC treated by embolization of microspheres combined with lipiodol

Primarily role of magnetization transfer contrast MR imaging for the rat with cirrhosis and HCC induced by DENA

Clinical significance of anatomical variation of hepatic artery in interventional therapy for HCC

Evaluation of Hepatic Chemoembolization and Percutaneous Ethanol Injection in the Treatment of HCC

Preparation of hepatocellular carcinoma-associated antigen HCC-22-5 antibody and its clinical significance in hepatic cirrhosis

The mechanism of moxibustion regulation of cellular apoptosis in HCC precancerous lesion

Gas Chromatographic Analysis of Naphthalene Compounds in HCC Diesel Fractions

Investigation of the mechanism of angiogenesis in growth and metastasis of HCC

Analysis of ESTs differentially expressed in HCC by Bioinformatics strategy

Initial Experience of Evaluating HCC Blood Supply before and after TACE Using CT Perfusion Imaging

Expression of hTERT gene and the relation between hTERT gene and clinicopathologic parameters in HCC

Antiandrogen treatment for nude mice model with ectopic transplanted human HCC

Values of serum tumor markers of HCC diagnosis among hepatitis involved liver cirrhosis

Clinical Value of Anatomical Variation of Hepatic Artery in Interventional Therapy for HCC

A comparative study on the TTV infection in the population of high and low prevalence area of HCC in Guangxi

Investigation on HBV and HCV infection among people of HCC, other malignant tumor and health

Expression and Biological Mechanism Exploration of HSP27 in Different Metastatic HCC Cell Lines

A study on factors influencing survival of HCC patients after hepatectomy

Recombinant adenovirus vectors carrying antisense MMP2 inhibit invasion of HCC cells in vitro

Apoptosis Effect of Immunizations with Fusions of Dendritic Cells and HCC Cells in Mice

Choice of operations for HCC patients with portal hypertension

Furthermore, een in candidates meeting the restrictive Milan criteria there is risk of HCC recurrence;

Autologous tumor vaccine for prevention and treatment of HCC

Benign tumor-like lesions of liver misinterpreted HCC diagnosis (74 cases reports)

Mortal's Legends and Tourism Image Plan for HCC: Taking Yibin as an Example

Relationship between ras p53 gene RNA and protein expression and HCC metastasis

New Color Doppler Method for Detecting HCC

Inducing effects of L-arginine on human HCC cells

COMPARATIVE ANALYSIS OF HCV AND HBV INFECTIONSIN HCC CASES AND IN OTHER PATIENTSWITH CHRONIC LIVER DISEASES

Observation and Nursing Care of Complications after TACE plus PSE for HCC

Clinical Analysis of 396 Fatal Patients with HCC in Beijing

Effects of all-trans retinoic acid with phenylacete natrium on human HCC cell line

Study on anti push process of HCC